FDA approves nasal spray for depression

The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K. It will be sold as Spravato. More specifically, it's for patients who have tried at least two other medications without success, and it should be taken with an oral antidepressant.
Read more: https://edition.cnn.com/2019/03/05/health/esketamine-depression-nasal-spray-fda-bn/index.html?source=Snapzu